• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗痴呆药物:按认知障碍程度开处方还是按社会经济群体开处方?

Antidementia drugs: prescription by level of cognitive impairment or by socio-economic group?

机构信息

Department of Mental Health Sciences (Archway campus), University College London, Highgate Hill, London N19 5NL, UK.

出版信息

Aging Ment Health. 2010 Jan;14(1):85-9. doi: 10.1080/13607860902918256.

DOI:10.1080/13607860902918256
PMID:20155524
Abstract

OBJECTIVES

We aimed to investigate for the first time whether cholinesterase inhibitor prescription was associated with economic status in a population of people with dementia.

METHOD

We recruited 215 people with dementia, living independently, who were consecutively referred to five Community Mental Health Teams in London and Essex. We tested our hypothesis that home owners were more likely to be prescribed cholinesterase inhibitors than those who rented their accommodation.

RESULTS

People who owned their home were four times more likely to be prescribed cholinesterase inhibitors (OR 4.2, 1.8-9.8; p = 0.001). Younger age, fewer neuropsychiatric symptoms, having a dementia diagnosis for which cholinesterase inhibitors were recommended and longer time since diagnosis also predicted prescription, but severity of cognitive impairment did not.

CONCLUSION

Despite high-profile guidelines that NHS cholinesterase prescribing should be restricted to people with moderate dementia, being a home owner was a strong predictor of prescription, while dementia severity was not. We recommend that health services should be audited to ensure that access to treatment increases in those who are socioeconomically disadvantaged.

摘要

目的

我们旨在首次探究在痴呆人群中,是否存在抗胆碱酯酶抑制剂的处方与经济状况有关。

方法

我们招募了 215 名独立生活的痴呆患者,他们连续被转介到伦敦和埃塞克斯的五家社区心理健康团队。我们检验了我们的假设,即房主比租房者更有可能被开抗胆碱酯酶抑制剂。

结果

拥有房产的人更有可能被开抗胆碱酯酶抑制剂(OR 4.2,1.8-9.8;p = 0.001)。年龄较小、神经精神症状较少、患有推荐使用抗胆碱酯酶抑制剂的痴呆症诊断以及诊断后时间较长也预测了处方,但认知障碍的严重程度没有预测到。

结论

尽管有明确的 NHS 抗胆碱酯酶药物使用指南,规定只应将其用于中度痴呆患者,但拥有房产是处方的一个强有力的预测因素,而痴呆症的严重程度不是。我们建议对卫生服务进行审核,以确保在社会经济处于不利地位的人群中增加治疗机会。

相似文献

1
Antidementia drugs: prescription by level of cognitive impairment or by socio-economic group?抗痴呆药物:按认知障碍程度开处方还是按社会经济群体开处方?
Aging Ment Health. 2010 Jan;14(1):85-9. doi: 10.1080/13607860902918256.
2
Determinants of antidementia drug prescription in patients older than 65: A latent class analysis.65 岁以上患者抗痴呆药物处方的决定因素:潜在类别分析。
Pharmacoepidemiol Drug Saf. 2020 Apr;29(4):444-452. doi: 10.1002/pds.4921. Epub 2020 Feb 17.
3
Observational cohort study: deprivation and access to anti-dementia drugs in the UK.观察性队列研究:英国的贫困状况与抗痴呆药物的可及性
Age Ageing. 2016 Jan;45(1):148-54. doi: 10.1093/ageing/afv154. Epub 2015 Nov 18.
4
Patterns of Dementia Treatment and Frank Prescribing Errors in Older Adults With Parkinson Disease.老年帕金森病患者痴呆治疗模式和明显处方错误。
JAMA Neurol. 2019 Jan 1;76(1):41-49. doi: 10.1001/jamaneurol.2018.2820.
5
[Drugs used for cognitive impairment. Analysis of 1.5 million prescriptions in Argentina].[用于认知障碍的药物。阿根廷150万张处方分析]
Medicina (B Aires). 2013;73(3):213-23.
6
Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia.在痴呆症患者中,停用或继续使用胆碱酯酶抑制剂、美金刚或两者。
Cochrane Database Syst Rev. 2021 Feb 3;2(2):CD009081. doi: 10.1002/14651858.CD009081.pub2.
7
Determinants Of Antipsychotic Drugs Prescription Among Community-Living Older Adults With Dementia: A Population-Based Study Using Health Information Systems In The Lazio Region, Italy.社区居住的老年痴呆症患者抗精神病药物处方的决定因素:意大利拉齐奥地区使用健康信息系统的基于人群的研究。
Clin Interv Aging. 2019 Nov 21;14:2071-2083. doi: 10.2147/CIA.S218641. eCollection 2019.
8
National patterns of dementia treatment among elderly ambulatory patients.老年门诊患者痴呆症治疗的全国模式。
J Natl Med Assoc. 2006 Mar;98(3):430-5.
9
Patterns and determinants of dementia pharmacotherapy in a population-based cohort of home care clients.基于人群的家庭护理客户队列中痴呆症药物治疗的模式和决定因素。
Drugs Aging. 2013 Jul;30(7):569-85. doi: 10.1007/s40266-013-0083-y.
10
Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.用于路易体痴呆、帕金森病痴呆及帕金森病认知障碍的胆碱酯酶抑制剂
Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD006504. doi: 10.1002/14651858.CD006504.pub2.

引用本文的文献

1
Inequalities in the Quality and Safety of Post-Diagnostic Primary Care for People With Dementia: A Scoping Review.痴呆症患者诊断后初级保健质量与安全方面的不平等:一项范围综述。
Int J Geriatr Psychiatry. 2024 Dec;39(12):e70035. doi: 10.1002/gps.70035.
2
Disparity in the use of Alzheimer's disease treatment in Southern Brazil.巴西南部阿尔茨海默病治疗利用的差距。
Sci Rep. 2023 Jun 12;13(1):9555. doi: 10.1038/s41598-023-36604-4.
3
Observational cohort study: deprivation and access to anti-dementia drugs in the UK.观察性队列研究:英国的贫困状况与抗痴呆药物的可及性
Age Ageing. 2016 Jan;45(1):148-54. doi: 10.1093/ageing/afv154. Epub 2015 Nov 18.
4
Determinants of treatment plan implementation in multidisciplinary team meetings for patients with chronic diseases: a mixed-methods study.慢性病患者多学科团队会议中治疗计划实施的决定因素:一项混合方法研究。
BMJ Qual Saf. 2014 Oct;23(10):867-76. doi: 10.1136/bmjqs-2014-002818. Epub 2014 Jun 9.
5
Rationing and deprivation: disease-modifying therapies for multiple sclerosis in the United Kingdom.配给和剥夺:英国多发性硬化症的疾病修正治疗。
Eur J Health Econ. 2013 Apr;14(2):315-21. doi: 10.1007/s10198-012-0378-7. Epub 2012 Jan 24.
6
Five skills psychiatrists should have in order to provide patients with optimal ethical care.精神科医生为患者提供最佳伦理关怀应具备的五项技能。
Innov Clin Neurosci. 2011 Mar;8(3):19-25.
7
Year in review: medication mishaps in the elderly.年度回顾:老年人用药失误
Am J Geriatr Pharmacother. 2011 Feb;9(1):1-10. doi: 10.1016/j.amjopharm.2011.01.003.